review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Justin R Hamilton | |
P433 | issue | 2 | |
P304 | page(s) | 61-65 | |
P577 | publication date | 2008-07-21 | |
P1433 | published in | Blood Reviews | Q15724415 |
P1476 | title | Protease-activated receptors as targets for antiplatelet therapy | |
P478 | volume | 23 |
Q42951363 | Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. |
Q33580620 | Differential signaling by protease-activated receptors: implications for therapeutic targeting. |
Q34255442 | Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease |
Q51522575 | Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood. |
Q38123237 | Investigational anticoagulants for hematological conditions: a new generation of therapies. |
Q33902628 | Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor |
Q41960992 | Personalized healthcare in clotting disorders |
Q90133870 | Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes |
Q50002204 | Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. |
Q58727906 | Rapid kinetics of changes in oxygen consumption rate in thrombin-stimulated platelets measured by high-resolution respirometry |
Q36110533 | Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice |
Q37687166 | Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents |
Q42920627 | The anti-platelet effects of apocynin in mice are not mediated by inhibition of NADPH oxidase activity |
Q38800853 | The pharmacodynamics of antiplatelet compounds in thrombosis treatment |
Q28246124 | Thrombin and vascular inflammation |
Q28281696 | Thrombin receptors and their antagonists: an update on the patent literature |
Search more.